Spero Legacy Sti, Inc.

Part of Spero Therapeutics, Inc.

UEI
VV22G4K3AZC4
CAGE
6WYX2
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
Corporate family
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Spero Legacy Sti, Inc.'s 2 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
A novel gyrase inhibitor for the treatment of drug-susceptible and multidrug-resistant mycobacterium tuberculosis… Grant · R44AI131749 National Institute of Allergy and Infectious Diseases $989,738
Development of compounds that expand the spectrum of antibacterial agents against key multidrug resistant… Grant · W81XWH1620019 Medical Command $1,503,380

Quick answers

What is Spero Legacy Sti, Inc.'s UEI?

Spero Legacy Sti, Inc.'s Unique Entity ID (UEI) in SAM.gov is VV22G4K3AZC4.

What is Spero Legacy Sti, Inc.'s CAGE code?

Spero Legacy Sti, Inc.'s CAGE code is 6WYX2.

What is Spero Legacy Sti, Inc.'s primary NAICS code?

Spero Legacy Sti, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).

Is Spero Legacy Sti, Inc. registered in SAM.gov?

Spero Legacy Sti, Inc.'s SAM.gov registration expired on December 12, 2020.

Who is Spero Legacy Sti, Inc.'s parent company?

Spero Legacy Sti, Inc. is part of Spero Therapeutics, Inc.

What is Spero Legacy Sti, Inc.'s most recent federal award?

Spero Legacy Sti, Inc.'s most recent federal grant award is A novel gyrase inhibitor for the treatment of drug-susceptible and multidrug-resistant mycobacterium tuberculosis… (R44AI131749), from National Institute of Allergy and Infectious Diseases, on March 1, 2017.

On GovTribe

See Spero Legacy Sti, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login